NFI-A disrupts myeloid cell differentiation and maturation in septic mice

Journal of Leukocyte Biology

Volumn 99, Issue 1, 2016, Pages 201-211

  McClure, Clara ^a   Ali, Ekram ^a   Youssef, Dima ^a   Yao, Zhi Q ^a   McCall, Charles E ^b   El Gazzar, Mohamed ^a  

^a East Tennessee State University   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Immune suppression; Inflammation; MDSC; MicroRNA; Sepsis

Indexed keywords

ANTAGOMIR; COLONY STIMULATING FACTOR 1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MICRORNA; MICRORNA 181B; MICRORNA 21; NUCLEAR FACTOR I; NUCLEAR FACTOR I A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MEMBRANE ANTIGEN; MIRN18 MICRORNA, MOUSE; MIRN21 MICRORNA, MOUSE; NFIA PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL DISRUPTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ECTOPIC EXPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; SUPPRESSOR CELL; ANIMAL; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM;

ANIMALS; ANTIGENS, SURFACE; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; IMMUNOMODULATION; MALE; MICE; MICRORNAS; MYELOID CELLS; NFI TRANSCRIPTION FACTORS; SEPSIS;

EID: 84953380005     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.4A0415-171RR     Document Type: Article

References (52)

1. Hotchkiss, R. S., Monneret, G., Payen, D. (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260-268.
2. Hotchkiss, R. S., Monneret, G., Payen, D. (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862-874.
3. Hutchins, N. A., Unsinger, J., Hotchkiss, R. S., Ayala, A. (2014) The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol. Med. 20, 224-233.
4. McCall, C. E., El Gazzar, M., Liu, T., Vachharajani, V., Yoza, B. (2011) Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J. Leukoc. Biol. 90, 439-446.
5. Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman II, S. D., Kreisel, D., Krupnick, A. S., Srivastava, A., Swanson, P. E., Green, J. M., Hotchkiss, R. S. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306, 2594-2605.
6. Cohen, J., Opal, S., Calandra, T. (2012) Sepsis studies need new direction. Lancet Infect. Dis. 12, 503-505.
7. Williams, S. C. (2012) After Xigris, researchers look to new targets to combat sepsis. Nat. Med. 18, 1001.
8. Angus, D. C. (2011) The search for effective therapy for sepsis: back to the drawing board? JAMA 306, 2614-2615.
9. Otto, G. P., Sossdorf, M., Claus, R. A., Rödel, J., Menge, K., Reinhart, K., Bauer, M., Riedemann, N. C. (2011) The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183.
10. McCall, C. E., Yoza, B., Liu, T., El Gazzar, M. (2010) Gene-specific epigenetic regulation in serious infections with systemic inflammation. J. Innate Immun. 2, 395-405.
11. Remick, D. G. (2007) Pathophysiology of sepsis. Am. J. Pathol. 170, 1435-1444.
12. Shelley, O., Murphy, T., Paterson, H., Mannick, J. A., Lederer, J. A. (2003) Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 20, 123-129.
13. Brudecki, L., Ferguson, D. A., Yin, D., Lesage, G. D., McCall, C. E., El Gazzar, M. (2012) Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis. Infect. Immun. 80, 602-611.
14. Brudecki, L., Ferguson, D. A., McCall, C. E., El Gazzar, M. (2012) Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80, 2026-2034.
15. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly- Scumpia, K. M., O’Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., Swan, R., Chung, C. S., Atkinson, M. A., Ramphal, R., Gabrilovich, D. I., Reeves, W. H., Ayala, A., Phillips, J., Laface, D., Heyworth, P. G., Clare-Salzler, M., Moldawer, L. L. (2007) MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474.
16. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Müller, M., Blander, J. M., Tacke, F., Trautwein, C. (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453-1464.
17. Cuenca, A. G., Delano, M. J., Kelly-Scumpia, K. M., Moreno, C., Scumpia, P. O., Laface, D. M., Heyworth, P. G., Efron, P. A., Moldawer, L. L. (2011) A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 17, 281-292.
18. Dai, J., El, G. M., Li, G. Y., Moorman, J. P., Yao, Z. Q. (2015) Myeloidderived suppressor cells: paradoxical roles in infection and immunity. J. Innate Immun. 7, 116-126.
19. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
20. Kong, Y. Y., Fuchsberger, M., Xiang, S. D., Apostolopoulos, V., Plebanski, M. (2013) Myeloid derived suppressor cells and their role in diseases. Curr. Med. Chem. 20, 1437-1444.
21. Ostrand-Rosenberg, S. (2010) Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol. Immunother. 59, 1593-1600.
22. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22, 238-244.
23. Ueda, Y., Kondo, M., Kelsoe, G. (2005) Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201, 1771-1780.
24. McClure, C., Brudecki, L., Ferguson, D. A., Yao, Z. Q., Moorman, J. P., McCall, C. E., El Gazzar, M. (2014) MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect. Immun. 82, 3816-3825.
25. Belikoff, B., Hatfield, S., Sitkovsky, M., Remick, D. G. (2011) Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice. Shock 35, 382-387.
26. Osuchowski, M. F., Welch, K., Siddiqui, J., Remick, D. G. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967-1974.
27. Mazuski, J. E., Sawyer, R. G., Nathens, A. B., DiPiro, J. T., Schein, M., Kudsk, K. A., Yowler, C.;Therapeutic Agents Committee of the Surgical Infections Society. (2002) The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg. Infect. (Larchmt) 3, 161-173.
28. Gronostajski, R. M. (2000) Roles of the NFI/CTF gene family in transcription and development. Gene 249, 31-45.
29. Ouellet, S., Vigneault, F., Lessard, M., Leclerc, S., Drouin, R., Guérin, S. L. (2006) Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells. Nucleic Acids Res. 34, 6472-6487.
30. Cheng, T., Rodrigues, N., Shen, H., Yang, Y., Dombkowski, D., Sykes, M., Scadden, D. T. (2000) Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804-1808.
31. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
32. Kusmartsev, S. A., Li, Y., Chen, S. H. (2000) Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 165, 779-785.
33. Ling, C., Chen, G., Chen, G., Zhang, Z., Cao, B., Han, K., Yin, J., Chu, A., Zhao, Y., Mao, X. (2012) A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo. Int. J. Cancer 131, 2411-2419.
34. Rashidian, J., Iyirhiaro, G. O., Park, D. S. (2007) Cell cycle machinery and stroke. Biochim. Biophys. Acta 1772, 484-493.
35. Dotto, G. P. (2000) p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471, M43-M56.
36. Dulić, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., Reed, S. I. (1994) p53-Dependent inhibition of cyclindependent kinase activities in human fibroblasts during radiationinduced G1 arrest. Cell 76, 1013-1023.
37. Liu, Y., Lai, L., Chen, Q., Song, Y., Xu, S., Ma, F., Wang, X., Wang, J., Yu, H., Cao, X., Wang, Q. (2012) MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J. Immunol. 188, 5500-5510.
38. Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., Struhl, K. (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 39, 493-506.
39. Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O’Connell, R. M., Baltimore, D. (2011) NF-kappaB dysregulation in microRNA-146adeficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. USA 108, 9184-9189.
40. Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., Bozzoni, I. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123, 819-831.
41. Rosa, A., Ballarino, M., Sorrentino, A., Sthandier, O., De Angelis, F. G., Marchioni, M., Masella, B., Guarini, A., Fatica, A., Peschle, C., Bozzoni, I. (2007) The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. USA 104, 19849-19854.
42. Laslo, P., Pongubala, J. M., Lancki, D. W., Singh, H. (2008) Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system. Semin. Immunol. 20, 228-235.
43. Wang, X., Huang, W., Yang, Y., Wang, Y., Peng, T., Chang, J., Caldwell, C. C., Zingarelli, B., Fan, G. C. (2014) Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis. Biochim. Biophys. Acta 1842, 701-711.
44. Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L. H., Broudy, V., Perlmutter, R. M., Kaushansky, K., Roberts, J. M. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733-744.
45. Li, L. Q., Li, X. L., Wang, L., Du, W. J., Guo, R., Liang, H. H., Liu, X., Liang, D. S., Lu, Y. J., Shan, H. L., Jiang, H. C. (2012) Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell. Physiol. Biochem. 30, 631-641.
46. García, M. G., Alaniz, L. D., Cordo Russo, R. I., Alvarez, E., Hajos, S. E. (2009) PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leuk. Res. 33, 288-296.
47. Yuan, T. L., Cantley, L. C. (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510.
48. Ma, X., Kumar, M., Choudhury, S. N., Becker Buscaglia, L. E., Barker, J. R., Kanakamedala, K., Liu, M. F., Li, Y. (2011) Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc. Natl. Acad. Sci. USA 108, 10144-10149.
49. Kusmartsev, S., Cheng, F., Yu, B., Nefedova, Y., Sotomayor, E., Lush, R., Gabrilovich, D. (2003) All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 63, 4441-4449.
50. Rawlings, J. S., Rosler, K. M., Harrison, D. A. (2004) The JAK/STAT signaling pathway. J. Cell Sci. 117, 1281-1283.
51. Condamine, T., Gabrilovich, D. I. (2011) Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32, 19-25.
52. Walton, A. H., Muenzer, J. T., Rasche, D., Boomer, J. S., Sato, B., Brownstein, B. H., Pachot, A., Brooks, T. L., Deych, E., Shannon, W. D., Green, J. M., Storch, G. A., Hotchkiss, R. S. (2014) Reactivation of multiple viruses in patients with sepsis. PLoS One 9, e98819.